Parexel International Corp (PRXL) 62.91 $PRXL
PAREXEL: Strong Competitive Advantages In A Growing Industry, But Shares Are Fully Valued
Investing Doc - at Seeking Alpha - Tue Feb 10, 9:23AM CST
PRXL: 62.91 (-0.18)
PAREXEL Recognized As A 2015 "Training Top 125" By Training Magazine
PR Newswire - Tue Feb 10, 8:00AM CST
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it has been recognized among top U.S. businesses in Training magazine's annual "Training Top 125." PAREXEL earned a place in the ranking this year for developing creative and effective employee learning and development initiatives for their global workforce.
PRXL: 62.91 (-0.18)
Insider Trading Alert - TEX, LBMH And PRXL Traded By Insiders
at The Street - Mon Feb 09, 10:30AM CST
Stocks with insider trader activity include TEX, LBMH and PRXL
PRXL: 62.91 (-0.18), TEX: 25.15 (+0.19), LBMH: 3.67 (+0.04)
PAREXEL International (PRXL) Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 1:10PM CST
PRXL: 62.91 (-0.18)
Parexel revises FY2015 guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 10:43AM CST
PRXL: 62.91 (-0.18)
PAREXEL International Q2 Earnings, Revenues Top Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:40AM CST
PAREXEL International Corp's (PRXL) second-quarter fiscal 2015 adjusted earnings of 69 cents per share surged nearly 35.3% year over year on expanding margins.
BGMD: 0.88 (unch), PRXL: 62.91 (-0.18), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)
Stocks Grind In Mixed Trade; McDonald's Jumps
at Investor's Business Daily - Thu Jan 29, 9:47AM CST
Stocks opened tightly mixed Thursday as corporate news and economic data ranged from good and bad to downright ugly. The Dow Jones industrial average held tight to an 0.1% gain. The Nasdaq slipped 0.3%, and the S&P 500 gave up 0.2%. The stock market...
F: 16.30 (-0.06), PRXL: 62.91 (-0.18), RYL: 45.55 (-0.06), FB: 75.74 (-0.49), QCOM: 70.88 (+0.49), PHM: 22.89 (+0.02), MCD: 95.65 (+0.56), LVS: 60.43 (+1.71), MTH: 41.94 (-0.09)
Parexel tops 2Q profit forecasts
Automated Insights - Wed Jan 28, 3:30PM CST
WALTHAM, Mass. (AP) _ Parexel International Corp. (PRXL) on Wednesday reported fiscal second-quarter net income of $38.8 million.
PRXL: 62.91 (-0.18)
PAREXEL beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 3:15PM CST
PRXL: 62.91 (-0.18)
PAREXEL International Reports Second Quarter Fiscal Year 2015 Results
PR Newswire - Wed Jan 28, 3:12PM CST
-- Gross new business wins of $964.4 million, up 15.3% year-over-year; net book-to-bill ratio of 1.54; backlog at $5.1 billion
PRXL: 62.91 (-0.18)
Icon, A Leader In Its Industry, Builds A Base
at Investor's Business Daily - Tue Jan 27, 5:12PM CST
New drugs require clinical trials and those trials increasingly have taken place on an international stage. Many top drug developers outsource an increasing share of trials to companies like Icon (ICLR). Based in Dublin, Icon is one of the top five...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), LH: 116.90 (+0.06), ICLR: 60.01 (+0.38), CVD: 107.08 (+0.05)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 4:35PM CST
GHL: 38.24 (+1.20), SLG: 128.59 (-0.65), AMP: 137.81 (+0.24), CTXS: 64.51 (+0.80), NOW: 77.55 (+1.60), MKSI: 35.56 (-0.25), EXTR: 3.46 (+0.10), CAVM: 62.86 (-0.55), VRTX: 113.66 (+4.03), ESIO: 6.50 (+0.02), JEC: 43.27 (+0.71), TTEK: 24.58 (+0.08), FB: 75.74 (-0.49), PTC: 34.02 (+0.37), CLB: 112.18 (+3.65), UMPQ: 16.82 (+0.17), IEX: 77.14 (+0.77), VAR: 92.65 (+0.03), AVB: 170.82 (-2.57), AZPN: 38.40 (+0.79), AF: 13.18 (+0.04), CGI: 25.30 (+0.05), SHOR: 7.48 (-0.03), FLEX: 12.05 (-0.09), CSII: 35.69 (+0.17), CPT: 75.24 (-1.03), KEX: 79.37 (+1.28), LVS: 60.43 (+1.71), TSCO: 84.26 (+0.99), STLD: 20.01 (+0.19), DHT: 6.99 (+0.05), MUR: 51.77 (+0.88), SWFT: 26.96 (+0.53), ALB: 54.59 (+0.63), IBKC: 63.08 (+0.45), QCOM: 70.88 (+0.49), CACI: 88.00 (+0.42), QGEN: 23.68 (-0.06), TER: 19.43 (+0.04), MEOH: 53.17 (+2.19), DRE: 21.63 (+0.04), SGI: 9.59 (+0.17), TGI: 61.33 (+1.18), CMO: 11.84 (+0.02), ATK: 140.03 (+0.78), ISIL: 15.30 (-0.25), ALGT: 178.42 (-4.07), GGP: 29.25 (-0.28), PRXL: 62.91 (-0.18), LRCX: 82.21 (+1.10), CRUS: 29.36 (+0.01), MLNX: 46.35 (+1.47), FTNT: 33.23 (+0.25), CBT: 47.04 (-0.10), HOLX: 30.46 (+0.21)
3 High-Flying Health Care Stock IPOs To Watch In 2015
at Investor's Business Daily - Wed Jan 21, 4:09PM CST
Judging by the recent price action of three health care names in today's IPO Leaders screen, the market is optimistic about future growth prospects. When an IPO prices below its proposed range, it's usually because of soft demand. But that wasn't the...
ALDR: 26.06 (+0.18), PRXL: 62.91 (-0.18), ILMN: 198.54 (+1.81), AGIO: 118.55 (+0.11), PRAH: 27.19 (+0.31), BMY: 60.04 (+0.56), ICLR: 60.01 (+0.38)
Stocks Off Modestly Near Midday; Skyworks Treks Up
at Investor's Business Daily - Tue Jan 20, 10:49AM CST
Stocks were modestly lower near Tuesday's halftime as oil prices remained under pressure. Hurt by energy stocks, the S&P 500 fell 0.4%. It was up as much as 0.5% near the open. West Texas Intermediate crude was off its low, but still down more than...
PRXL: 62.91 (-0.18), SWKS: 81.85 (-0.57), RGR: 43.60 (+0.61), SWHC: 12.63 (-0.20), OUTR: 68.39 (+2.22)
Downgrade Alert for Parexel International (PRXL)
Comtex SmarTrend(R) - Tue Jan 20, 7:13AM CST
Parexel International (NASDAQ
RXL) was downgraded from Buy to Neutral at SunTrust today. The stock closed yesterday at $62.91 on volume of 602,000 shares, below average daily volume of 636,000. Parexel International (NASDAQ RXL) defies analysts with a current price ($62.91) 2.2% above its average consensus price target of $61.50. The stock should find initial support at its 50-day moving average (MA) of $56.84 and further support at its 200-day MA of $55.22.
PRXL: 62.91 (-0.18)
Ulta Among IBD 50 Stocks Setting Up In Shaky Market
at Investor's Business Daily - Fri Jan 16, 5:44PM CST
The stock market so far in 2015 calls for wariness on the part of investors. As during much of 2014, leading stocks break out, then move sideways, or a breakout fails and the stock heads south. But this week's edition of the IBD 50 list does include...
BCC: 42.88 (+0.26), PRXL: 62.91 (-0.18), UTHR: 151.11 (+3.59), IDXX: 159.08 (+1.72), ULTA: 136.66 (+0.59), AAPL: 127.08 (+0.62)
Contract Research Organization (CRO) Market 2019 Global Forecasts in New Research Reports
PR Newswire - Wed Jan 07, 10:30AM CST
ReportsnReports.com adds "Global CRO Market 2015-2019" research report of 75 pages to the healthcare and pharmaceuticals industry intelligence collection of its online business research and data library.
PRXL: 62.91 (-0.18), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
PAREXEL International To Present At JP Morgan Healthcare Conference
PR Newswire - Mon Jan 05, 9:00AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Wednesday, January 14, 2015, in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at 11:00 a.m. PT.
PRXL: 62.91 (-0.18)
Will Health Yield Wealth For Recent IPO INC Research?
at Investor's Business Daily - Wed Dec 31, 3:53PM CST
What's the prescription for stirring up investor enthusiasm in the IPO market? INC Research Holdings (INCR) may have found the answer. INC is a contract research organization, or CRO, which provides phase one to phase four clinical development...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
Recent IPO PRA Health Sciences Finds Growth In Buyout
at Investor's Business Daily - Tue Dec 30, 4:16PM CST
Recent IPO PRA Health Sciences may have gotten a tepid reception from investors out of the gate. But the global contract research organization, or CRO, has been making up for lost time ever since. PRA (PRAH) went public in November at $18, below...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
PAREXEL: Strong Competitive Advantages In A Growing Industry, But Shares Are Fully Valued
Investing Doc - at Seeking Alpha - Tue Feb 10, 9:23AM CST
PRXL: 62.91 (-0.18)
PAREXEL Recognized As A 2015 "Training Top 125" By Training Magazine
PR Newswire - Tue Feb 10, 8:00AM CST
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it has been recognized among top U.S. businesses in Training magazine's annual "Training Top 125." PAREXEL earned a place in the ranking this year for developing creative and effective employee learning and development initiatives for their global workforce.
PRXL: 62.91 (-0.18)
Insider Trading Alert - TEX, LBMH And PRXL Traded By Insiders
at The Street - Mon Feb 09, 10:30AM CST
Stocks with insider trader activity include TEX, LBMH and PRXL
PRXL: 62.91 (-0.18), TEX: 25.15 (+0.19), LBMH: 3.67 (+0.04)
PAREXEL International (PRXL) Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 1:10PM CST
PRXL: 62.91 (-0.18)
Parexel revises FY2015 guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 10:43AM CST
PRXL: 62.91 (-0.18)
PAREXEL International Q2 Earnings, Revenues Top Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 10:40AM CST
PAREXEL International Corp's (PRXL) second-quarter fiscal 2015 adjusted earnings of 69 cents per share surged nearly 35.3% year over year on expanding margins.
BGMD: 0.88 (unch), PRXL: 62.91 (-0.18), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)
Stocks Grind In Mixed Trade; McDonald's Jumps
at Investor's Business Daily - Thu Jan 29, 9:47AM CST
Stocks opened tightly mixed Thursday as corporate news and economic data ranged from good and bad to downright ugly. The Dow Jones industrial average held tight to an 0.1% gain. The Nasdaq slipped 0.3%, and the S&P 500 gave up 0.2%. The stock market...
F: 16.30 (-0.06), PRXL: 62.91 (-0.18), RYL: 45.55 (-0.06), FB: 75.74 (-0.49), QCOM: 70.88 (+0.49), PHM: 22.89 (+0.02), MCD: 95.65 (+0.56), LVS: 60.43 (+1.71), MTH: 41.94 (-0.09)
Parexel tops 2Q profit forecasts
Automated Insights - Wed Jan 28, 3:30PM CST
WALTHAM, Mass. (AP) _ Parexel International Corp. (PRXL) on Wednesday reported fiscal second-quarter net income of $38.8 million.
PRXL: 62.91 (-0.18)
PAREXEL beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 3:15PM CST
PRXL: 62.91 (-0.18)
PAREXEL International Reports Second Quarter Fiscal Year 2015 Results
PR Newswire - Wed Jan 28, 3:12PM CST
-- Gross new business wins of $964.4 million, up 15.3% year-over-year; net book-to-bill ratio of 1.54; backlog at $5.1 billion
PRXL: 62.91 (-0.18)
Icon, A Leader In Its Industry, Builds A Base
at Investor's Business Daily - Tue Jan 27, 5:12PM CST
New drugs require clinical trials and those trials increasingly have taken place on an international stage. Many top drug developers outsource an increasing share of trials to companies like Icon (ICLR). Based in Dublin, Icon is one of the top five...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), LH: 116.90 (+0.06), ICLR: 60.01 (+0.38), CVD: 107.08 (+0.05)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 4:35PM CST
GHL: 38.24 (+1.20), SLG: 128.59 (-0.65), AMP: 137.81 (+0.24), CTXS: 64.51 (+0.80), NOW: 77.55 (+1.60), MKSI: 35.56 (-0.25), EXTR: 3.46 (+0.10), CAVM: 62.86 (-0.55), VRTX: 113.66 (+4.03), ESIO: 6.50 (+0.02), JEC: 43.27 (+0.71), TTEK: 24.58 (+0.08), FB: 75.74 (-0.49), PTC: 34.02 (+0.37), CLB: 112.18 (+3.65), UMPQ: 16.82 (+0.17), IEX: 77.14 (+0.77), VAR: 92.65 (+0.03), AVB: 170.82 (-2.57), AZPN: 38.40 (+0.79), AF: 13.18 (+0.04), CGI: 25.30 (+0.05), SHOR: 7.48 (-0.03), FLEX: 12.05 (-0.09), CSII: 35.69 (+0.17), CPT: 75.24 (-1.03), KEX: 79.37 (+1.28), LVS: 60.43 (+1.71), TSCO: 84.26 (+0.99), STLD: 20.01 (+0.19), DHT: 6.99 (+0.05), MUR: 51.77 (+0.88), SWFT: 26.96 (+0.53), ALB: 54.59 (+0.63), IBKC: 63.08 (+0.45), QCOM: 70.88 (+0.49), CACI: 88.00 (+0.42), QGEN: 23.68 (-0.06), TER: 19.43 (+0.04), MEOH: 53.17 (+2.19), DRE: 21.63 (+0.04), SGI: 9.59 (+0.17), TGI: 61.33 (+1.18), CMO: 11.84 (+0.02), ATK: 140.03 (+0.78), ISIL: 15.30 (-0.25), ALGT: 178.42 (-4.07), GGP: 29.25 (-0.28), PRXL: 62.91 (-0.18), LRCX: 82.21 (+1.10), CRUS: 29.36 (+0.01), MLNX: 46.35 (+1.47), FTNT: 33.23 (+0.25), CBT: 47.04 (-0.10), HOLX: 30.46 (+0.21)
3 High-Flying Health Care Stock IPOs To Watch In 2015
at Investor's Business Daily - Wed Jan 21, 4:09PM CST
Judging by the recent price action of three health care names in today's IPO Leaders screen, the market is optimistic about future growth prospects. When an IPO prices below its proposed range, it's usually because of soft demand. But that wasn't the...
ALDR: 26.06 (+0.18), PRXL: 62.91 (-0.18), ILMN: 198.54 (+1.81), AGIO: 118.55 (+0.11), PRAH: 27.19 (+0.31), BMY: 60.04 (+0.56), ICLR: 60.01 (+0.38)
Stocks Off Modestly Near Midday; Skyworks Treks Up
at Investor's Business Daily - Tue Jan 20, 10:49AM CST
Stocks were modestly lower near Tuesday's halftime as oil prices remained under pressure. Hurt by energy stocks, the S&P 500 fell 0.4%. It was up as much as 0.5% near the open. West Texas Intermediate crude was off its low, but still down more than...
PRXL: 62.91 (-0.18), SWKS: 81.85 (-0.57), RGR: 43.60 (+0.61), SWHC: 12.63 (-0.20), OUTR: 68.39 (+2.22)
Downgrade Alert for Parexel International (PRXL)
Comtex SmarTrend(R) - Tue Jan 20, 7:13AM CST
Parexel International (NASDAQ
RXL) was downgraded from Buy to Neutral at SunTrust today. The stock closed yesterday at $62.91 on volume of 602,000 shares, below average daily volume of 636,000. Parexel International (NASDAQ RXL) defies analysts with a current price ($62.91) 2.2% above its average consensus price target of $61.50. The stock should find initial support at its 50-day moving average (MA) of $56.84 and further support at its 200-day MA of $55.22. PRXL: 62.91 (-0.18)
Ulta Among IBD 50 Stocks Setting Up In Shaky Market
at Investor's Business Daily - Fri Jan 16, 5:44PM CST
The stock market so far in 2015 calls for wariness on the part of investors. As during much of 2014, leading stocks break out, then move sideways, or a breakout fails and the stock heads south. But this week's edition of the IBD 50 list does include...
BCC: 42.88 (+0.26), PRXL: 62.91 (-0.18), UTHR: 151.11 (+3.59), IDXX: 159.08 (+1.72), ULTA: 136.66 (+0.59), AAPL: 127.08 (+0.62)
Contract Research Organization (CRO) Market 2019 Global Forecasts in New Research Reports
PR Newswire - Wed Jan 07, 10:30AM CST
ReportsnReports.com adds "Global CRO Market 2015-2019" research report of 75 pages to the healthcare and pharmaceuticals industry intelligence collection of its online business research and data library.
PRXL: 62.91 (-0.18), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
PAREXEL International To Present At JP Morgan Healthcare Conference
PR Newswire - Mon Jan 05, 9:00AM CST
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Wednesday, January 14, 2015, in San Francisco. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at 11:00 a.m. PT.
PRXL: 62.91 (-0.18)
Will Health Yield Wealth For Recent IPO INC Research?
at Investor's Business Daily - Wed Dec 31, 3:53PM CST
What's the prescription for stirring up investor enthusiasm in the IPO market? INC Research Holdings (INCR) may have found the answer. INC is a contract research organization, or CRO, which provides phase one to phase four clinical development...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
Recent IPO PRA Health Sciences Finds Growth In Buyout
at Investor's Business Daily - Tue Dec 30, 4:16PM CST
Recent IPO PRA Health Sciences may have gotten a tepid reception from investors out of the gate. But the global contract research organization, or CRO, has been making up for lost time ever since. PRA (PRAH) went public in November at $18, below...
PRXL: 62.91 (-0.18), Q: 63.31 (+0.06), INCR: 24.19 (-0.45), ILMN: 198.54 (+1.81), PRAH: 27.19 (+0.31), CVD: 107.08 (+0.05)
